Isowighteone attenuates vascular calcification by targeting HSP90AA1-mediated PI3K-Akt pathway and suppressing osteogenic gene expression

Isowighteone demonstrates significant therapeutic potential by effectively downregulating the expression of osteogenic genes, alleviating vascular calcification, and suppressing the HSP90AA1/PI3K/Akt signaling pathway, thereby improving pathological conditions associated with vascular calcification. These above results not only elucidate isowighteone as a novel therapeutic agent against VC through selective suppression of osteogenic differentiation but also position this phytochemical as a clinically candidate for VC management.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2025-08-20
DOI
https://doi.org/10.3389/fbioe.2025.1636883
Primary Topic
Phytochemistry and biological activities of Ficus species
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Isowighteone attenuates vascular calcification by targeting HSP90AA1-mediated PI3K-Akt pathway and suppressing osteogenic gene expression

Jiahui Peng, Yaoxin Liu, Yuanxi Mo, Rui Yang et al.
Frontiers in Bioengineering and Biotechnology
Phytochemistry and biological activities of Ficus species
article

Isowighteone attenuates vascular calcification by targeting HSP90AA1-mediated PI3K-Akt pathway and suppressing osteogenic gene expression

Jiahui Peng, Yaoxin Liu, Yuanxi Mo, Rui Yang, Zhaoyan Xu, Wanzi Hong, Qian Huang, An Hye Jin, Ning Tan, Lei Jiang, Qiqi Song, Yuqi Cheng, Wing Tak Wong
article en

Abstract

Isowighteone demonstrates significant therapeutic potential by effectively downregulating the expression of osteogenic genes, alleviating vascular calcification, and suppressing the HSP90AA1/PI3K/Akt signaling pathway, thereby improving pathological conditions associated with vascular calcification. These above results not only elucidate isowighteone as a novel therapeutic agent against VC through selective suppression of osteogenic differentiation but also position this phytochemical as a clinically candidate for VC management.

Frontiers in Bioengineering and BiotechnologyVol. 13
Hong Kong Polytechnic University (HK), Hunan University (CN), First People's Hospital of Foshan (CN), Wuhan Textile University (CN), Guangdong Academy of Medical Sciences (CN), Guangdong Provincial People's Hospital (CN), South China University of Technology (CN)
National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, National Science and Technology Major Project
Openalex Percentile: Top 84%
Phytochemistry and biological activities of Ficus species
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Isowighteone attenuates vascular calcification by targeting HSP90AA1-mediated PI3K-Akt pathway and suppressing osteogenic gene expression — Jiahui Peng, Yaoxin Liu, et al. · Frontiers in Bioengineering and Biotechnology (2025) | TGRS Research Map | TGRS